Search Results - "Mebarki, Mouniya"

Imaging mass spectrometry reveals modified forms of histone H4 as new biomarkers of microvascular invasion in hepatocellular carcinomas by Poté, Nicolas, Alexandrov, Theodore, Le Faouder, Julie, Laouirem, Samira, Léger, Thibaut, Mebarki, Mouniya, Belghiti, Jacques, Camadro, Jean‐Michel, Bedossa, Pierre, Paradis, Valérie

“…Microvascular invasion (MiVI) is a major risk factor in postoperative tumor recurrence and mortality in hepatocellular carcinoma (HCC). Unfortunately, this…”
Get full text

Cullin7: a new gene involved in liver carcinogenesis related to metabolic syndrome by Paradis, Valerie, Albuquerque, Miguel, Mebarki, Mouniya, Hernandez, Lucie, Zalinski, Stephane, Quentin, Samuel, Belghiti, Jacques, Soulier, Jean, Bedossa, Pierre

“…Metabolic syndrome (MS) is an emerging risk factor in hepatocellular carcinoma (HCC). HCC related to MS may occur either in advanced fibrosis or before the…”
Get more information

Anti-angiogenic effect of metformin in human liver carcinogenesis related to metabolic syndrome by Cauchy, François, Mebarki, Mouniya, Albuquerque, Miguel, Laouirem, Samira, Rautou, Pierre Emmanuel, Soubrane, Olivier, Raymond, Eric, Bedossa, Pierre, Paradis, Valérie

Get more information

Strong antineoplastic effects of metformin in preclinical models of liver carcinogenesis by Cauchy, François, Mebarki, Mouniya, Leporq, Benjamin, Laouirem, Samira, Albuquerque, Miguel, Lambert, Simon, Bourgoin, Pierre, Soubrane, Olivier, Van Beers, Bernard E, Faivre, Sandrine, Bedossa, Pierre, Paradis, Valérie

“…Studies suggest that metformin, widely used for treating Type 2 diabetes, possesses innate antineoplastic properties. For metabolic syndrome patients with…”
Get more information

Progression from cirrhosis to cancer is associated with early ubiquitin post-translational modifications: identification of new biomarkers of cirrhosis at risk of malignancy by Laouirem, Samira, Le Faouder, Julie, Alexandrov, Theodore, Mestivier, Denis, Léger, Thibaut, Baudin, Xavier, Mebarki, Mouniya, Paradis, Valérie, Camadro, Jean-Michel, Bedossa, Pierre

“…Cirrhosis is a lesion at risk of hepatocellular carcinoma (HCC). Identifying mechanisms associated with the transition from cirrhosis to HCC and characterizing…”
Get full text

P57 - Hepatocellular carcinoma protein carbonylation in virus C and metabolic syndrome patients by Martin, Fernando Ariel, Mebarki, Mouniya, Paradis, Valérie, Friguet, Bertrand, Radman, Miroslav

“…Metabolic syndrome (MS) is becoming the leading cause of chronic liver diseases worldwide. Hepatocellular carcinoma (HCC) development in MS is peculiar…”
Get full text

Hepatocellular carcinoma protein carbonylation in virus C and metabolic syndrome patients by Martin, Fernando Ariel, Mebarki, Mouniya, Paradis, Valérie, Friguet, Bertrand, Radman, Miroslav

“…Metabolic syndrome (MS) is becoming the leading cause of chronic liver diseases worldwide. Hepatocellular carcinoma (HCC) development in MS is peculiar…”
Get full text

Abstract 3345: Induction of apoptosis by high levels of oscillatory shear strain: proof of concept in a human colon cancer metastasis cell line by Garteiser, Philippe, Doblas, Sabrina, Lambert, Simon, Mebarki, Mouniya, Vilgrain, Valerie, Van Beers, Bernard E., Paradis, Valerie, Sinkus, Ralph

“…Purpose / Introduction: Mechanotransduction is a biological process enabling cells to convert mechanical cues into biological responses[1]. The apoptotic…”
Get full text

The expression of the hypoxia markers CA9 and CXCR4 is correlated with survival in patients with neuroendocrine tumours of the ileum by Deschamps, Lydia, Bacha, Dhouha, Rebours, Vinciane, Mebarki, Mouniya, Bretagnol, Frédéric, Panis, Yves, Bedossa, Pierre, Ruszniewski, Philippe, Couvelard, Anne

“…The hypoxia-inducible factor pathway regulates the expression of a diverse group of molecules such as CA9 and CXCR4. Our aim was to investigate the expression…”
Get more information